Key result
Bradykinin infusion suppresses post-MI inducible sustained ventricular tachycardia in ~67% of pigs.
Why the study?
The antiarrhythmic effect of ACE inhibitors may be partly due to elevation of endogenous bradykinin levels, but the in vivo effect of bradykinin on inducible sustained VT after myocardial infarction was unclear.
Does bradykinin infusion reduce the inducibility of sustained ventricular tachycardia in pigs 2 weeks after myocardial infarction?
Does bradykinin infusion reduce the inducibility of sustained ventricular tachycardia in pigs 2 weeks after myocardial infarction?
Exogenous bradykinin reduced the inducibility of sustained VT in a post-MI pig model, suggesting the antiarrhythmic effect of ACE inhibitors may be partly due to elevated endogenous bradykinin levels.
Answers are grounded in this paper and cite their sources.
May support bradykinin-mediated antiarrhythmic effects of ACE inhibitors; hypothesis-generating in a post-MI animal model and requires clinical translation.
We studied the in vivo effect of bradykinin infusion on inducible sustained ventricular tachycardia (VT) 2 weeks after myocardial infarction in pigs, based on the assumption that the antiarrhythmic effect of angiotensin-converting enzyme (ACE) inhibitors may, apart from their angiotensin-II lowering effect, also be due to elevation of endogenous bradykinin levels. Of the six pigs with inducible VT in the control state, four were noninducible during subsequent bradykinin infusion (p less than 0.05). The ventricular effective refractory period (VERP) did not change during bradykinin infusion (from 237 +/- 37 to 239 +/- 42 ms), nor did intraventricular conduction change (filtered QRS duration was 45 +/- 17 ms before and 43 +/- 19 ms during infusion). Bradykinin caused both a significant systolic blood pressure (SBP) decrease (from 79 +/- 14 to 49 +/- 4 mm Hg, p less than 0.001) and diastolic BP (DBP) decrease (from 41 +/- 10 to 27 +/- 4 mm Hg, p less than 0.01). In conclusion, exogenous bradykinin reduced the inducibility of sustained VT 2 weeks after myocardial infarction. Because refractory periods or conduction velocity were not affected, the mechanism of action might be associated with the BP decrease, which can decrease wall stress. The previously reported antiarrhythmic effect of ACE inhibitors may be due in part to elevation of endogenous bradykinin levels.
No takes yet. Share an insight, caveat, or question.
Tolle et al. (1991) studied Myocardial Infarction (n=6). Bradykinin infusion vs. Control state was evaluated on Inducibility of sustained ventricular tachycardia (p=<0.05). Bradykinin infusion rendered 4 out of 6 pigs with previously inducible sustained ventricular tachycardia noninducible 2 weeks after myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: